Consumer Advisory Committee (CAC)
The Consumer Advisory Committee (CAC) provides PHARMAC with input from a patient or health consumer perspective. It was established in 2002 following the requirements of the New Zealand Public Health and Disability Act 2000 and provides advice to PHARMAC on a broad range of PHARMAC's activities, including around medicines funding issues. It is not, however, involved in the assessment of pharmaceutical funding applications.
The Committee meets at least twice a year, and is guided by its Terms of Reference (26 pages, 586 KB). Minutes of meetings are available here.
For more information about the Consumer Advisory Committee and other ways PHARMAC obtains consumer views, read the Engaging with consumers (1 page, 174 KB) information sheet.
Page updated on 16 Sep 2011
Linked documents
Consumer Advisory Committee Terms of Reference (26 pages, 586 KB)
1 CONTENTS 1 2 3 Establishment…4 1.1 2.1 3.1 3.2 3.3 4 5 6 7 8 4.1 The CAC …..4 Purpose of the CAC …4 Relationship with PHARMAC…..5 Relationship with PHARMAC staff…5 Indemnity for Members…..6 Appointment of the CAC Members…
Engaging with consumers (1 page, 174 KB)
Pharmaceutical Management Agency information sheet Engaging with consumers PHARMAC always seeks to keep in touch with the community’s views on pharmaceutical-related issues and to involve consumers in its work. The Consumer Advisory Committee (CAC) is one way PHARMAC ensures it…
